The build-up to and subsequent outcome of the Patient Capital Review were major talking points for the tax-efficient space and, writes Jack Rose, its implementation and impact look set to be similar in the year ahead
2017 has been another good year for the Enterprise Investment Scheme (EIS) and venture capital trust (VCT) space. Fund-raising levels have remained high and government support for associated legislation means there are increasing numbers of new advisers and their clients looking at and investing in the sector. The 16/17 tax year saw the second highest fundraising figures on record for VCTs with more than £540m raised and, although we are still mid-17/18 tax year, at this stage it seems likely the VCT sector will again eclipse these figures, with some £400m already raised - and we are yet...
To continue reading this article...
Join Professional Adviser
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence.
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters.
- Make smart business decisions with the latest developments in regulation, investing retirement and protection.
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes.
